Drug company accused of trying to block trials aimed at promoting a 'cheap, safe and effective' treatment for sight loss on the NHS . 
 It 'bullied' experts who tried to prove drug can be used to treat blindness . 
 Avastin is effective at tackling wet age-related macular degeneration . 
 Cheaper than the current treatment it would save NHS Â£102million a year . 
 